Author details

Full Name

Alice M Walsh

Affiliation

ORCID

Career Start Year

2004

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36863094	Pharmacodynamic activity of BMS-986156, a glucocorticoid-induced TNF receptor-related protein agonist, alone or in combination with nivolumab in patients with advanced solid tumors.	ESMO Open	2023
35932450	A multi-omic single cell sequencing approach to develop a CD8 T cell specific gene signature for anti-PD1 response in solid tumors.	International Journal of Cancer	2022
33407110	Rapid single cell evaluation of human disease and disorder targets using REVEAL: SingleCellâ¿¢.	BMC Genomics	2021
35602225	Pan-cancer analysis of the effect of biopsy site on tumor mutational burden observations.	Commun Med (Lond)	2021
33658305	Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC.	J Immunother Cancer	2021
33288543	Integration of the Transcriptome and Genome-Wide Landscape of BRD2 and BRD4 Binding Motifs Identifies Key Superenhancer Genes and Reveals the Mechanism of Bet Inhibitor Action in Rheumatoid Arthritis Synovial Fibroblasts.	Journal of Immunology	2021
32405062	Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors.	Nat Med	2020
32312757	<i>STK11</i> and <i>KEAP1</i> mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort.	ESMO Open	2020
31486842	Clinical Validation of PBRM1 Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma.	JAMA Oncol	2019
29720240	Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus.	Arthritis Res Ther	2018
30518680	Enriched Cd141+ DCs in the joint are transcriptionally distinct, activated, and contribute to joint pathogenesis.	JCI insight	2018
29489833	Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression.	PLoS ONE	2018
28455435	CD40L-Dependent Pathway Is Active at Various Stages of Rheumatoid Arthritis Disease Progression.	Journal of Immunology	2017
28863153	Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways.	PLoS ONE	2017
27140173	Integrative genomic deconvolution of rheumatoid arthritis GWAS loci into gene and cell type associations.	Genome Biol	2016
27282753	Joint-specific DNA methylation and transcriptome signatures in rheumatoid arthritis identify distinct pathogenic processes.	Nat Commun	2016
25934697	Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma.	Mol Cancer Res	2015
25074920	p53Î¨ is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state.	Proc Natl Acad Sci U S A	2014
24445374	Differential parsing of EGFR endocytic flux among parallel internalization pathways in lung cancer cells with EGFR-activating mutations.	Integrative Biology (United Kingdom)	2014
23868981	Regulation of EGFR trafficking and cell signaling by Sprouty2 and MIG6 in lung cancer cells.	Journal of Cell Science	2013
15130998	We are not "amueslied".	BMJ, The	2004